Please verify that you are a Healthcare Professional. Register for complete access to all the content!
Google the pain
Test content
23 minNovel Tofacitinib Generics: Pioneering 50% csDMARD...
Tofacitinib generics offer a practical solution for patients with axial spondyloarthritis (axSpA) by reducing the need for conventional synthetic disease-modify...
3 minSevere illness from COVID-19 increases susceptibil...
According to a trial, severe COVID-19 disease is linked to higher levels of the tumour necrosis factor-alpha (TNF-α), interleukin (IL)-1, IL-6, and pro-in...
3 minZoledronic acid reduces blood lipid levels in post...
In postmenopausal females with lipid disorders and osteoporosis, treatment with zoledronic acid combined with atorvastatin or zoledronic acid alone considerably...
2 minFirst COVID-19 treatment received FDA approval
On 22 October 2020, the United States Food and Drug Administration (USFDA) granted its approval to remdesivir (antiviral drug) for use in adult and pediatric...
4 minSublingual Cyclobenzaprine (TNX-102 SL) emerges as...
A phase 3, double-blind, randomized, placebo-controlled trial (RELIEF) illustrated that administration of TNX-102 SL (sublingual [SL] formulation of Cyclobenzap...
3 minDexamethasone found to reduce pain due to periapic...
A study published in “The Journal of Emergency Medicine” depicted that in patients with dental periapical abscess pain, single-dose dexamethasone as an adjunc...
3 minConsider nimesulide as a therapeutic adjuvant to r...
A commentary published in “SLAS Discovery” recommended that nimesulide should be considered for inclusion in the list of drugs to be tested for identifying t...
4 minUse of proton pump inhibitors do not increase risk...
A recent research in the Gastroenterology journal fortified the safety of appropriate usage of proton pump inhibitors therapy during COVID-19. As found, the u...
3 minVirtual reality system is now FDA approved for low...
According to the press release of Food and Drug Administration (FDA) on November 16, 2021, the prescription-use immersive virtual reality (VR) system has bee...
3 minPeople with gastrointestinal disorders have an elevated risk of cardiovascular d...
Reinforcing secondary cardiovascular disease prevention in patients with gastrointestinal diseases is crucial, specifically for peripheral artery disease and co...
NSAIDs prove effective and safe for postoperative pain management in sinonasal s...
NSAIDs, when used in sinonasal surgery, effectively reduce postoperative pain and the occurrence of postoperative nausea, while posing no increased risk of post...
Virtual reality training unveils significant benefits for Parkinson's patients
Utilizing virtual reality training could prove beneficial in the rehabilitation of people afflicted by Parkinson's disease.
New study reveals effectiveness of potential analgesics for emergency endodontic...
Patients with severe dental pain can be recommended Novafen and Ibuprofen for emergency pain relief.
Gene variations can significantly influence Sufentanil labor pain relief
Understanding how genetic factors impact Sufentanil's effectiveness in labor pain relief can pave the way for more personalized pain management strategies.
FDA releases alert regarding invasive disease risk in preterm infants receiving...
As per the FDA, the administration of probiotics formulated to contain live bacteria or yeast to preterm infants in hospital settings poses a significant risk o...
WHO recommends multivitamins for pregnancy in updated essential medicines list
WHO has updated its Essential Medicines List to include a range of essential multivitamins and micronutrient supplements for pregnant women, aiming to enhance m...
FDA greenlights first biosimilar for multiple sclerosis treatment
For the management of multiple sclerosis, the FDA has granted approval to the first biosimilar (Natalizumab-sztn).
WHO recommends Rituximab off-label use in multiple sclerosis
WHO has endorsed groundbreaking public health measures concerning novel Essential Medicines for the treatment of multiple sclerosis.
FDA greenlights first-ever oral medication for postpartum depression
Zuranolone has received FDA approval for addressing postpartum depression in adults.
FDA approves revolutionary cellular therapy, Lantidra, for type 1 diabetes treat...
FDA approval of Lantidra offers hope to adults suffering from type 1 diabetes who struggle with severe hypoglycemia, despite intensive management efforts.
This website uses cookies to help us give you the best experience when you visit.
By using this website you consent to our use of cookies. For more information please review our cookie policy.